• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年社区获得性尿路感染住院患者中多重耐药菌的临床影响。

Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection.

机构信息

Internal Medicine Department, Doctor Peset University Hospital, Avda. Gaspar Aguilar, n 90, 46017, Valencia, Spain.

Microbiology Department, Doctor Peset University Hospital, Avda. Gaspar Aguilar, n 90, 46017, Valencia, Spain.

出版信息

BMC Infect Dis. 2021 Dec 7;21(1):1232. doi: 10.1186/s12879-021-06939-2.

DOI:10.1186/s12879-021-06939-2
PMID:34876045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8653523/
Abstract

INTRODUCTION

Previous studies have described some risk factors for multidrug-resistant (MDR) bacteria in urinary tract infection (UTI). However, the clinical impact of MDR bacteria on older hospitalized patients with community-acquired UTI has not been broadly analyzed. We conducted a study in older adults with community-acquired UTI in order to identify risk factors for MDR bacteria and to know their clinical impact.

METHODS

Cohort prospective observational study of patients of 65 years or older, consecutively admitted to a university hospital, diagnosed with community-acquired UTI. We compared epidemiological and clinical variables and outcomes, from UTI due to MDR and non-MDR bacteria. Independent risk factors for MDR bacteria were analyzed using logistic regression.

RESULTS

348 patients were included, 41.4% of them with UTI due to MDR bacteria. Median age was 81 years. Hospital mortality was 8.6%, with no difference between the MDR and non-MDR bacteria groups. Median length of stay was 5 [4-8] days, with a longer stay in the MDR group (6 [4-8] vs. 5 [4-7] days, p = 0.029). Inadequate empirical antimicrobial therapy (IEAT) was 23.3%, with statistically significant differences between groups (33.3% vs. 16.2%, p < 0.001). Healthcare-associated UTI variables, in particular previous antimicrobial therapy and residence in a nursing home, were found to be independent risk factors for MDR bacteria.

CONCLUSIONS

The clinical impact of MDR bacteria was moderate. MDR bacteria cases had higher IEAT and longer hospital stay, although mortality was not higher. Previous antimicrobial therapy and residence in a nursing home were independent risk factors for MDR bacteria.

摘要

介绍

先前的研究已经描述了尿路感染(UTI)中多重耐药(MDR)细菌的一些危险因素。然而,MDR 细菌对社区获得性 UTI 的老年住院患者的临床影响尚未广泛分析。我们对患有社区获得性 UTI 的老年人进行了一项研究,以确定 MDR 细菌的危险因素,并了解其临床影响。

方法

对连续入住一所大学医院的 65 岁或以上的社区获得性 UTI 患者进行队列前瞻性观察研究。我们比较了 MDR 和非 MDR 细菌引起的 UTI 的流行病学和临床变量以及结局。使用逻辑回归分析 MDR 细菌的独立危险因素。

结果

共纳入 348 例患者,其中 41.4%的患者 UTI 由 MDR 细菌引起。中位年龄为 81 岁。医院死亡率为 8.6%,MDR 和非 MDR 细菌组之间无差异。中位住院时间为 5 [4-8] 天,MDR 组的住院时间更长(6 [4-8] 与 5 [4-7] 天,p = 0.029)。经验性抗菌治疗不足(IEAT)为 23.3%,两组之间存在统计学差异(33.3%比 16.2%,p < 0.001)。医疗保健相关 UTI 变量,特别是先前的抗菌治疗和居住在疗养院,被发现是 MDR 细菌的独立危险因素。

结论

MDR 细菌的临床影响中等。MDR 细菌病例的 IEAT 更高,住院时间更长,但死亡率并未更高。先前的抗菌治疗和居住在疗养院是 MDR 细菌的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9432/8653523/b2114a88d55a/12879_2021_6939_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9432/8653523/b2114a88d55a/12879_2021_6939_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9432/8653523/b2114a88d55a/12879_2021_6939_Fig1_HTML.jpg

相似文献

1
Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection.老年社区获得性尿路感染住院患者中多重耐药菌的临床影响。
BMC Infect Dis. 2021 Dec 7;21(1):1232. doi: 10.1186/s12879-021-06939-2.
2
Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections.社区获得性与医源性尿路感染:与社区获得性和医院获得性尿路感染的比较。
J Infect. 2012 May;64(5):478-83. doi: 10.1016/j.jinf.2012.01.010. Epub 2012 Jan 20.
3
Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study.高多重耐药率国家中与导尿管相关的尿路感染住院患者的临床结局:COMBACTE-MAGNET RESCUING 研究。
Antimicrob Resist Infect Control. 2019 Dec 3;8:198. doi: 10.1186/s13756-019-0656-6. eCollection 2019.
4
Risk factors of multidrug-resistant bacteria in community-acquired urinary tract infections.社区获得性尿路感染中多重耐药菌的危险因素。
Afr Health Sci. 2021 Mar;21(1):214-219. doi: 10.4314/ahs.v21i1.28.
5
Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.肝硬化患者医院获得性多重耐药泌尿道感染的流行病学和危险因素:塞尔维亚单中心经验。
BMC Infect Dis. 2019 Feb 12;19(1):141. doi: 10.1186/s12879-019-3761-5.
6
Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.产超广谱β-内酰胺酶细菌引起的尿路感染:危险因素及抗生素耐药性
Pediatr Int. 2019 Nov;61(11):1127-1132. doi: 10.1111/ped.13911. Epub 2019 Nov 13.
7
Trends and predictors of antimicrobial resistance among patients with urinary tract infections at a tertiary hospital facility in Alexandria, Egypt: a retrospective record-based classification and regression tree analysis.埃及亚历山大一家三级医院尿路感染患者的抗菌药物耐药趋势和预测因素:回顾性基于记录的分类和回归树分析。
BMC Infect Dis. 2024 Feb 22;24(1):246. doi: 10.1186/s12879-024-09086-6.
8
Predictive factors for Enterococcus faecalis in complicated community-acquired urinary tract infections in older patients.预测老年患者复杂社区获得性尿路感染中粪肠球菌的因素。
Geriatr Gerontol Int. 2020 Mar;20(3):183-186. doi: 10.1111/ggi.13856. Epub 2019 Dec 25.
9
Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain.医疗机构相关性血流感染尿源性细菌的多药耐药危险因素和临床影响:西班牙一项多中心前瞻性队列的事后分析。
J Hosp Infect. 2024 Sep;151:173-185. doi: 10.1016/j.jhin.2024.05.020. Epub 2024 Jun 28.
10
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.铜绿假单胞菌尿路感染的特征及危险因素分析:明确那些可能由多药耐药菌株引起的感染。
Int J Antimicrob Agents. 2020 Apr;55(4):105900. doi: 10.1016/j.ijantimicag.2020.105900. Epub 2020 Jan 10.

引用本文的文献

1
Design of Miniprotein Inhibitors of Bacterial Adhesins.细菌粘附素微型蛋白抑制剂的设计
bioRxiv. 2025 Aug 18:2025.08.18.670751. doi: 10.1101/2025.08.18.670751.
2
Bacterial profile and antimicrobial susceptibility pattern of urinary tract infection among diabetic patients at Bule Hora University Teaching Hospital, Southern Ethiopia.埃塞俄比亚南部布勒霍拉大学教学医院糖尿病患者尿路感染的细菌谱及抗菌药物敏感性模式
Sci Rep. 2025 Jul 6;15(1):24112. doi: 10.1038/s41598-025-05782-8.
3
Nature of antimicrobial resistance of pathogens causing urinary tract infection in Bangladesh: age and gender profiles.

本文引用的文献

1
Emergence of Extended-Spectrum β-Lactamase Urinary Tract Infections Among Hospitalized Emergency Department Patients in the United States.美国住院急诊科患者中出现的超广谱β-内酰胺酶尿路感染。
Ann Emerg Med. 2021 Jan;77(1):32-43. doi: 10.1016/j.annemergmed.2020.08.022. Epub 2020 Oct 31.
2
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.基于体外药敏结果不一致的血流感染经验性抗生素治疗不当:美国医院的患病率、预测因素和死亡风险的回顾性队列分析。
Lancet Infect Dis. 2021 Feb;21(2):241-251. doi: 10.1016/S1473-3099(20)30477-1. Epub 2020 Sep 8.
3
孟加拉国引起尿路感染的病原体的抗菌药物耐药性特征:年龄和性别分布情况
Microbiol Spectr. 2025 Jun 3;13(6):e0228724. doi: 10.1128/spectrum.02287-24. Epub 2025 Apr 25.
4
Nonenteric Pathogens in Urinary Tract Infections: Epidemiology and Resistance Patterns in Albania.尿路感染中的非肠道病原体:阿尔巴尼亚的流行病学与耐药模式
Glob Health Epidemiol Genom. 2025 Apr 17;2025:9944598. doi: 10.1155/ghe3/9944598. eCollection 2025.
5
Burden of multi-drug resistant bacterial isolates and its associated risk factors among UTI-confirmed geriatrics in Gondar town.贡德尔镇确诊为尿路感染的老年患者中多重耐药细菌分离株的负担及其相关危险因素。
Sci Rep. 2025 Apr 24;15(1):14270. doi: 10.1038/s41598-025-89123-9.
6
Cranberry-derived bioactives for the prevention and treatment of urinary tract infections: antimicrobial mechanisms and global research trends in nutraceutical applications.蔓越莓衍生生物活性物质在预防和治疗尿路感染中的应用:抗菌机制及营养保健品应用的全球研究趋势
Front Nutr. 2025 Feb 26;12:1502720. doi: 10.3389/fnut.2025.1502720. eCollection 2025.
7
Effect of Inadequate Treatment in Adult Patients with Community-Acquired Acute Pyelonephritis Due to Enterobacterales Under Empirical Management with Cefazolin.在经验性使用头孢唑林治疗的情况下,大肠埃希菌所致社区获得性急性肾盂肾炎成年患者治疗不充分的影响。
Antibiotics (Basel). 2025 Feb 14;14(2):197. doi: 10.3390/antibiotics14020197.
8
The Clinical Implications of Inappropriate Therapy in Community-Onset Urinary Tract Infections and the Development of a Bayesian Hierarchical Weighted-Incidence Syndromic Combination Antibiogram.社区获得性尿路感染不恰当治疗的临床意义及贝叶斯分层加权发病率综合征组合抗菌谱的建立
Antibiotics (Basel). 2025 Feb 12;14(2):187. doi: 10.3390/antibiotics14020187.
9
Aerobic bacteria study, clinical spectrum, and outcome of patients with community-acquired multidrug-resistant pathogens.社区获得性多重耐药病原体患者的需氧菌研究、临床谱及转归
J Family Med Prim Care. 2024 Nov;13(11):5052-5059. doi: 10.4103/jfmpc.jfmpc_680_24. Epub 2024 Nov 18.
10
The incidence, clinical features and outcome of urinary tract infections in geriatric patients: A prospective longitudinal study.老年患者尿路感染的发病率、临床特征及转归:一项前瞻性纵向研究。
IJID Reg. 2024 Oct 11;13:100469. doi: 10.1016/j.ijregi.2024.100469. eCollection 2024 Dec.
Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- Producing .
尿路感染的治疗失败:产超广谱β-内酰胺酶的多重耐药性强毒株的警示例证
Infect Drug Resist. 2020 Jun 17;13:1839-1850. doi: 10.2147/IDR.S256131. eCollection 2020.
4
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.美国住院患者中耐多药细菌感染,2012-2017 年。
N Engl J Med. 2020 Apr 2;382(14):1309-1319. doi: 10.1056/NEJMoa1914433.
5
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
6
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.铜绿假单胞菌尿路感染的特征及危险因素分析:明确那些可能由多药耐药菌株引起的感染。
Int J Antimicrob Agents. 2020 Apr;55(4):105900. doi: 10.1016/j.ijantimicag.2020.105900. Epub 2020 Jan 10.
7
Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study.高多重耐药率国家中与导尿管相关的尿路感染住院患者的临床结局:COMBACTE-MAGNET RESCUING 研究。
Antimicrob Resist Infect Control. 2019 Dec 3;8:198. doi: 10.1186/s13756-019-0656-6. eCollection 2019.
8
Management of Extended-Spectrum Beta-Lactamase Urinary Tract Infections: Diagnostic and Treatment Considerations for the Older Adult.超广谱β-内酰胺酶所致尿路感染的管理:老年患者的诊断与治疗考量
Sr Care Pharm. 2019 Dec 1;34(10):645-659. doi: 10.4140/TCP.n.2019.645.
9
Characteristics of febrile urinary tract infections in older male adults.老年男性发热性尿路感染的特征。
BMC Geriatr. 2019 Nov 29;19(1):334. doi: 10.1186/s12877-019-1360-3.
10
Inadequate empirical antimicrobial treatment in older people with bacteremic urinary tract infection who reside in nursing homes: A multicenter prospective observational study.在居住在养老院的患有菌血症性尿路感染的老年人中,经验性抗菌治疗不足:一项多中心前瞻性观察研究。
Geriatr Gerontol Int. 2019 Nov;19(11):1112-1117. doi: 10.1111/ggi.13776. Epub 2019 Oct 1.